StonvexLoading…
StonvexCore line items from INCY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.40B | $1.27B | $5.14B | $3.63B | $2.27B |
Operating Income | Not available | $301.12M | $1.51B | $1.18B | $735.48M |
Net Income | Not available | $303.33M | $1.29B | $987.37M | $405.00M |
EPS (Diluted) | $1.87 | $1.47 | $6.41 | $4.95 | $2.84 |
Total Assets | Not available | $7.34B | $6.96B | $6.33B | $5.82B |
Total Liabilities | Not available | $1.72B | $1.79B | $1.68B | $1.65B |
Cash & Equivalents | Not available | $3.46B | $3.10B | $2.46B | $1.95B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 199.95M | 198.46M | 196.13M | 194.12M |